{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Limb-Girdle+Muscular+Dystrophy+Type+2A", "query": { "condition": "Limb-Girdle Muscular Dystrophy Type 2A" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 7, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T07:50:28.912Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00893334", "title": "Evaluation of Limb-Girdle Muscular Dystrophy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Becker Muscular Dystrophy", "Limb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency)", "Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency)", "Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)" ], "interventions": [], "intervention_types": [], "sponsor": "Cooperative International Neuromuscular Research Group", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2009-04", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2014-03-07", "last_synced_at": "2026-05-22T07:50:28.912Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia • Charlotte, North Carolina", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00893334" }, { "nct_id": "NCT05230459", "title": "A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Limb Girdle Muscular Dystrophy", "Limb-Girdle Muscular Dystrophy Type 2", "LGMD2I", "Muscular Dystrophy", "LGMD2", "LGMD", "FKRP", "FKRP Mutation", "Fukutin Related Protein" ], "interventions": [ { "name": "AB-1003 dose level 1", "type": "GENETIC" }, { "name": "AB-1003 dose level 2", "type": "GENETIC" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "GENETIC", "OTHER" ], "sponsor": "AskBio Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 10, "start_date": "2023-05-15", "completion_date": "2032-12", "has_results": false, "last_update_posted_date": "2026-02-20", "last_synced_at": "2026-05-22T07:50:28.912Z", "location_count": 6, "location_summary": "Irvine, California • Iowa City, Iowa • Kansas City, Kansas + 3 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05230459" }, { "nct_id": "NCT04475926", "title": "A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Limb-girdle Muscular Dystrophy" ], "interventions": [], "intervention_types": [], "sponsor": "Sarepta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": null, "sex": "ALL", "summary": "4 Years and older" }, "enrollment_count": 205, "start_date": "2021-04-22", "completion_date": "2030-09-05", "has_results": false, "last_update_posted_date": "2025-11-06", "last_synced_at": "2026-05-22T07:50:28.912Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • La Jolla, California + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04475926" }, { "nct_id": "NCT03488784", "title": "Natural History of Limb Girdle Muscular Dystrophy Type 2A and Type 2E", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Limb-Girdle Muscular Dystrophy Type 2A", "Limb-Girdle Muscular Dystrophy, Type 2E" ], "interventions": [], "intervention_types": [], "sponsor": "Lindsay Alfano", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 100, "start_date": "2016-11-29", "completion_date": "2025-08-11", "has_results": false, "last_update_posted_date": "2025-08-14", "last_synced_at": "2026-05-22T07:50:28.912Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03488784" }, { "nct_id": "NCT05989620", "title": "Long-Term Development of Muscular Dystrophy Outcome Assessments", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "LGMD1B", "LGMD1C", "LGMD1D", "LGMD1E", "LGMD1F", "LGMD1G", "LGMD1H", "LGMD2A", "LGMD2B", "LGMD2C", "LGMD2D", "LGMD2E", "LGMD2F", "LGMD2G", "LGMD2I", "LGMD2J", "LGMD2K", "LGMD2L", "LGMD2M", "LGMD2N", "LGMD2O", "LGMD2P", "LGMD2Q", "LGMD2S", "LGMD2T", "LGMD2U", "LGMD2W", "LGMD2X", "LGMD2Y" ], "interventions": [], "intervention_types": [], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "6 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "6 Years to 50 Years" }, "enrollment_count": 1000, "start_date": "2023-10-18", "completion_date": "2029-05-01", "has_results": false, "last_update_posted_date": "2025-11-18", "last_synced_at": "2026-05-22T07:50:28.912Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05989620" }, { "nct_id": "NCT05618080", "title": "LGMD R1 Natural History Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A", "Limb Girdle Muscular Dystrophy", "Limb Girdle Muscular Dystrophy Type R1", "LGMD2A" ], "interventions": [], "intervention_types": [], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "12 Years to 50 Years" }, "enrollment_count": 100, "start_date": "2024-01-31", "completion_date": "2028-08", "has_results": false, "last_update_posted_date": "2025-06-08", "last_synced_at": "2026-05-22T07:50:28.912Z", "location_count": 10, "location_summary": "Orange, California • Aurora, Colorado • Gainesville, Florida + 7 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Shipshewana", "state": "Indiana" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT05618080" }, { "nct_id": "NCT05902351", "title": "Natural History Study for Charcot Marie Tooth Disease", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Charcot-Marie-Tooth Disease", "Charcot-Marie-Tooth", "Charcot-Marie-Tooth Disease, Type IA", "Charcot-Marie-Tooth Disease Type 2A", "Charcot-Marie-Tooth Disease Type 2", "Charcot-Marie-Tooth Disease, Type 2C", "Charcot-Marie-Tooth Disease Type 2A2B", "Charcot-Marie-Tooth Disease Type 2B2", "Charcot-Marie-Tooth Disease Type 2A1", "Charcot-Marie-Tooth Disease Type 4B1", "Charcot-Marie-Tooth Disease, Type IB", "Charcot-Marie-Tooth Disease Type 2B1", "Charcot-Marie-Tooth Disease Type 2U (Diagnosis)", "Charcot-Marie-Tooth Disease Type 4A", "Charcot-Marie-Tooth Disease, Type 4A, Axonal Form", "Charcot-Marie-Tooth Disease Type 2A2A", "Charcot-Marie-Tooth Disease Type 2S (Disorder)", "Charcot-Marie-Tooth Disease and Deafness", "Charcot-Marie-Tooth Disease Type 4B2", "Charcot-Marie-Tooth Disease Type 4H", "Charcot-Marie-Tooth Disease Type 1F", "Charcot-Marie-Tooth Disease Type 4C", "Charcot-Marie-Tooth Disease Type 4E", "Charcot-Marie-Tooth Disease Type 1D", "Charcot-Marie-Tooth Disease Type 2Q (Diagnosis)", "Charcot-Marie-Tooth Disease Type 2A2", "Charcot-Marie-Tooth Disease Type 2N (Diagnosis)", "Charcot-Marie-Tooth Disease Type 2B5", "Charcot-Marie-Tooth Disease Type 2D", "Charcot-Marie-Tooth Disease Type 4D", "Charcot-Marie-Tooth Disease Type 2K", "Charcot-Marie-Tooth Disease Type 2L (Diagnosis)", "Charcot-Marie-Tooth Disease Type 2T", "Charcot-Marie-Tooth Disease Type 2I", "Charcot-Marie-Tooth Disease Type 2J", "Charcot-Marie-Tooth Disease Type 2E", "Charcot-Marie-Tooth Disease Type 2G", "Charcot-Marie-Tooth Disease Type 1C", "Charcot-Marie-Tooth Disease Type 2R", "Charcot-Marie-Tooth Disease Type 2O (Diagnosis)", "Charcot-Marie-Tooth Disease Type 2M", "Charcot-Marie-Tooth Disease Type 2P", "Charcot-Marie-Tooth Disease Type 2Y", "Charcot-Marie-Tooth Disease Type 4F (Diagnosis)", "Charcot-Marie-Tooth Disease Type 4B3", "Charcot-Marie-Tooth Disease Type 2H", "HNPP", "X-Linked Charcot-Marie-Tooth Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Hereditary Neuropathy Foundation", "sponsor_class": "OTHER_GOV", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 10000, "start_date": "2013-11-01", "completion_date": "2029-12-31", "has_results": false, "last_update_posted_date": "2024-10-01", "last_synced_at": "2026-05-22T07:50:28.912Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05902351" } ] }